Total Liabilities for Incyte (INCY)
According to Incyte's latest reported financial statements, the company's latest reported total liabilities is $1.72B USD. Total liabilities sum everything the company owes at the end of each reporting period — accounts payable, accrued expenses, debt, lease obligations, and other claims — as filed on the balance sheet. Compare with total assets and net assets for solvency context.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
INCY
Currently viewingTotal LiabilitiesSwitch metric
Latest period
$1.72B
YoY change
-9.7%
5Y CAGR
+13.7%
Peak year (2024)
$2.00B
Latest annual
$1.80B
Total Liabilities history chart for Incyte (INCY) from 1993 to 2025
Total Liabilities history table for Incyte (INCY) from 1993 to 2025
| Fiscal year | Period ended | Reported | Total Liabilities | YoY |
|---|---|---|---|---|
| 2025 | $1.80B | -9.7% | ||
| 2024 | $2.00B | +25.4% | ||
| 2023 | $1.59B | +8.3% | ||
| 2022 | $1.47B | +26.4% | ||
| 2021 | $1.16B | +22.5% | ||
| 2020 | $949.65M | +14.6% | ||
| 2019 | $828.34M | +15.1% | ||
| 2018 | $719.79M | +7.1% | ||
| 2017 | $671.95M | -44.9% | ||
| 2016 | $1.22B | +45.8% | ||
| 2015 | $836.28M | -4.8% | ||
| 2014 | $878.11M | +6.7% | ||
| 2013 | $822.68M | +62.8% | ||
| 2012 | $505.38M | -9.1% | ||
| 2011 | $556.04M | -3.8% | ||
| 2010 | $578.23M | -29.0% | ||
| 2009 | $814.77M | +79.8% | ||
| 2008 | $453.14M | +4.1% | ||
| 2007 | $435.21M | -0.8% | ||
| 2006 | $438.51M | +11.4% | ||
| 2005 | $393.50M | -10.2% | ||
| 2004 | $438.40M | +94.7% | ||
| 2003 | $225.21M | -9.8% | ||
| 2002 | $249.73M | -5.9% | ||
| 2001 | $265.36M | +0.5% | ||
| 2000 | $264.13M | +411.9% | ||
| 1999 | $51.60M | +1.8% | ||
| 1998 | $50.70M | -5.1% | ||
| 1997 | $53.40M | +146.1% | ||
| 1996 | $21.70M | +97.3% | ||
| 1995 | $11.00M | +134.0% | ||
| 1994 | $4.70M | +213.3% | ||
| 1993 | $1.50M | — |
Total Liabilities values are taken from Incyte's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2025's annual total liabilities for Incyte (INCY) came in at $1.80B – declined 9.7% year-over-year.
Incyte total liabilities has recorded the values shown across consecutive periods, with a +13.7% compound annual growth rate over 2020–2025 (5 years).
2024 marks the peak total liabilities at $2.00B, with the historical low of $1.50M recorded in 1993.
Incyte (INCY) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $101.80B.
Incyte Total Liabilities by Year
Incyte Total Liabilities 2025: $1.80B
Incyte total liabilities in 2025 was $1.80B, declined 9.7% below 2024.
Incyte Total Liabilities 2024: $2.00B
Incyte total liabilities in 2024 was $2.00B, grew 25.4% from 2023. This figure represents the highest annual value in the available history.
Incyte Total Liabilities 2023: $1.59B
Incyte total liabilities in 2023 was $1.59B, grew 8.3% from 2022.
Incyte Total Liabilities 2022: $1.47B
Incyte total liabilities in 2022 was $1.47B, grew 26.4% from 2021.
Incyte Total Liabilities 2021: $1.16B
Incyte total liabilities in 2021 was $1.16B.
See more financial history for Incyte (INCY).
Sector peers — Total Liabilities
Companies in the same sector as Incyte, ranked by their latest total liabilities.
| Company | Total Liabilities | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $348.86B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $207.88B | Healthcare |
| AbbVie Inc. (ABBV) | $137.19B | Healthcare |
| Johnson & Johnson (JNJ) | $117.67B | Healthcare |
| Eli Lilly and Company (LLY) | $85.94B | Healthcare |
| Merck & Co., Inc. (MRK) | $84.20B | Healthcare |
| Amgen Inc. (AMGN) | $81.93B | Healthcare |
| AstraZeneca PLC (AZN) | $65.36B | Healthcare |
Frequently asked questions
What is Incyte's total liabilities?
- Latest reported total liabilities for Incyte (INCY) is $1.72B (period ending March 31, 2026).
How has Incyte total liabilities changed year-over-year?
- Incyte (INCY) total liabilities changed -9.7% year-over-year on the latest annual filing.
What is the long-term growth rate of Incyte total liabilities?
- Incyte (INCY) total liabilities compound annual growth rate is +13.7% over the most recent 5 years available.
When did Incyte total liabilities hit its highest annual value?
- Incyte total liabilities reached its highest annual value of $2.00B in 2024.
What was Incyte total liabilities in 2024?
- Incyte (INCY) total liabilities in 2024 was $2.00B.
What was Incyte total liabilities in 2025?
- Incyte (INCY) total liabilities in 2025 was $1.80B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
INCY Overview
Company profile, financial tools, and key metrics
INCY Revenue Counter
Earns $163.03 every second. See per minute, hour, and day.
INCY Earnings Counter
Earns $40.80 per second net profit. See per minute, hour, and day.
INCY Economic Scale
Exceeds Eswatini's GDP. Compare with world economies.
INCY What If Invested
What if you had invested $1,000? See historical returns from any date.
INCY How It Makes Money
Discover visual breakdown of $5.14B in revenue — where it comes from and where it goes.
INCY Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
INCY Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
INCY Daily Price Character
Explosive · 48.3% historical win rate (green days). Streaks & record days.
INCY Buybacks
0.10% TTM buyback yield. Shareholder yield & SBC comparison.
INCY Stock Split History
2 splits on record. Dates, ratios, and cumulative multiple.